510(k) K820192

HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM by Hyland Therapeutic Div., Travenol Laboratories — Product Code GRP

K820192 is an FDA 510(k) premarket notification submitted by Hyland Therapeutic Div., Travenol Laboratories for the device "HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM". The FDA issued a decision of Substantially Equivalent on Mar 11, 1982. The device falls under product code GRP (Antisera, All Types, H. Influenza), a Class II device regulated under 21 CFR 866.3300. Hyland Therapeutic Div., Travenol Laboratories has 43 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 11, 1982
Date Received
Jan 25, 1982
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Antisera, All Types, H. Influenza
Device Class
Class II
Regulation Number
866.3300
Review Panel
MI
Submission Type
510(k) Exempt

Need the full FDA record for Hyland Therapeutic Div., Travenol Laboratories? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K820192. Report a data issue: hello@regdatalab.com.